NORTH CHINA PHARMACEUTICAL HUASHENG CO LTD

Overview

NORTH CHINA PHARMACEUTICAL HUASHENG CO LTD is an active pharmaceutical ingredient (API) supplier with 8 active FDA Type II Drug Master Files, covering AMPHOTERICIN B USP NON-STERILE BULK DRUG; BACITRACIN USP; BACITRACIN ZINC NON-STERILE BULK DRUG SUBSTANCE; CYCLOSPORINE USP, NON-STERILE BULK DRUG SUBSTANCE; FIDAXOMICIN; POLYMYXIN B SULFATE USP.

API / Drug Master Files

NORTH CHINA PHARMACEUTICAL HUASHENG CO LTD holds 8 active (8 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• POLYMYXIN B SULFATE USPActive2021-07-08
• TACROLIMUS USPActive2020-03-25
• CYCLOSPORINE USP, NON-STERILE BULK DRUG SUBSTANCEActive2019-06-15
• FIDAXOMICINActive2015-09-29
• VANCOMYCIN HYDROCHLORIDEActive2015-09-02
• BACITRACIN USPActive2014-08-29
• BACITRACIN ZINC NON-STERILE BULK DRUG SUBSTANCEActive2009-12-04
• AMPHOTERICIN B USP NON-STERILE BULK DRUGActive2005-03-10

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to NORTH CHINA PHARMACEUTICAL HUASHENG CO LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.